Oligopeptide P11-4 has emerged as a fascinating molecule in the realm of scientific research, offering promising applications across various fields. This short peptide, with its unique structural properties and biological activities, has captured the attention of researchers worldwide. In this comprehensive exploration, we'll delve into the diverse ways Oligopeptide P11-4 is utilized in scientific investigations, focusing on its role in biomimetic dentistry, drug design, and its safety profile for human use.
Oligopeptide P11-4 CAS 593266-60-5
Product Code: BM-2-4-109
CAS number: 593266-60-5
Molecular formula: C72H98N20O22
Molecular weight: 1595.69
EINECS number: /
MDL No.: MFCD00076292
Hs code: /
Analysis items: HPLC>99.0%, LC-MS
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Changzhou Factory
Technology service: R&D Dept.-4
Usage: Pure API(Active pharmaceutical ingredient) for science research only
Shipping: Shipping as another no sensitive chemical compound name
We provide Oligopeptide P11-4 CAS 593266-60-5, please refer to the following website for detailed specifications and product information.
Product:https://www.bloomtechz.com/synthetic-chemical/peptide/oligopeptide-p11-4-cas-593266-60-5.html
The Role of Oligopeptide P11-4 in Biomimetic Dentistry: Mechanisms and Applications
Biomimetic dentistry, an innovative approach that aims to mimic natural tooth structures and processes, has found a valuable ally in Oligopeptide P11-4(https://en.wikipedia.org/wiki/Oligopeptide_P11-4). This peptide has shown remarkable potential in promoting dental enamel regeneration and remineralization, offering new possibilities for non-invasive dental treatments.
The mechanism behind P11-4's efficacy in dental applications lies in its self-assembling properties. When applied to tooth surfaces, this peptide forms a three-dimensional matrix that serves as a scaffold for the deposition of calcium and phosphate ions. This biomimetic process closely resembles the natural formation of tooth enamel, allowing for the repair of early carious lesions and the strengthening of weakened enamel.
Researchers have conducted numerous studies to evaluate the effectiveness of P11-4 in various dental scenarios. One notable investigation examined its ability to remineralize artificial caries lesions in vitro. The results demonstrated that P11-4 significantly enhanced the remineralization process, outperforming conventional fluoride treatments in certain aspects.
Moreover, the application of Oligopeptide P11-4 extends beyond caries prevention. Scientists are exploring its potential in addressing dentinal hypersensitivity, a common dental problem characterized by sharp, transient pain in response to various stimuli. The peptide's ability to form a protective layer over exposed dentinal tubules shows promise in reducing sensitivity and improving patient comfort.
The versatility of P11-4 in biomimetic dentistry has led to the development of various dental products incorporating this peptide. These range from professional treatments applied in dental offices to over-the-counter products for home use. As research progresses, we can anticipate even more innovative applications of Oligopeptide P11-4 in the field of dentistry, potentially revolutionizing dental care practices.
Biomedical Applications of P11-4 in Drug Design
Beyond its dental applications, Oligopeptide P11-4 has piqued the interest of researchers in the broader field of drug design and delivery. Its unique properties make it an attractive candidate for developing novel therapeutic strategies across various medical domains.
One of the most intriguing aspects of P11-4 in drug design is its potential as a drug delivery vehicle. The self-assembling nature of this peptide allows for the creation of nanostructures that can encapsulate and transport therapeutic agents. This characteristic opens up possibilities for targeted drug delivery, potentially enhancing the efficacy of treatments while minimizing side effects.
Researchers are exploring the use of P11-4-based nanocarriers for a wide range of applications, including cancer therapy, gene delivery, and treatment of neurological disorders. For instance, studies have shown that P11-4 nanostructures can effectively deliver anticancer drugs to tumor sites, improving their therapeutic index.
In the realm of regenerative medicine, Oligopeptide P11-4 has shown promise in tissue engineering applications. Its ability to form hydrogels with tunable properties makes it an excellent candidate for creating scaffolds that support cell growth and tissue regeneration. Scientists are investigating its potential in promoting bone regeneration, wound healing, and even neural tissue repair.
The versatility of P11-4 extends to its potential in developing antimicrobial therapies. Research has demonstrated that certain modifications to the peptide sequence can imbue it with antimicrobial properties, opening up possibilities for combating antibiotic-resistant bacteria.
Furthermore, the peptide's ability to self-assemble into various nanostructures has led to investigations into its use in diagnostic applications. P11-4-based biosensors and imaging agents are being developed, potentially offering new tools for early disease detection and monitoring.
As our understanding of Oligopeptide P11-4's properties and interactions with biological systems deepens, we can expect to see an expansion of its applications in drug design and biomedical research. The peptide's adaptability and biocompatibility make it a valuable asset in the quest for innovative therapeutic strategies.
Is Oligopeptide P11-4 Safe for Human Use?
As with any compound being considered for medical applications, the safety profile of Oligopeptide P11-4 is of paramount importance. Extensive research has been conducted to evaluate its biocompatibility and potential adverse effects, particularly in the context of its dental applications where direct human exposure is most common.
The good news is that studies have consistently demonstrated a favorable safety profile for P11-4. Its peptide nature means that it is composed of naturally occurring amino acids, which generally pose a low risk of toxicity or adverse reactions. Moreover, the body's natural processes can easily break down and eliminate these peptides, further reducing the likelihood of long-term negative effects.
Clinical trials focusing on the use of P11-4 in dental applications have reported no significant adverse events. Patients treated with P11-4-based products for enamel regeneration or caries prevention have shown good tolerability, with no reports of allergic reactions or other concerning side effects.
However, it's important to note that as with any medical treatment, individual responses can vary. Some people may experience mild, transient effects such as temporary tooth sensitivity or gum irritation, particularly when using higher concentrations of the peptide. These effects are typically short-lived and resolve without intervention.
In the context of its potential use in drug delivery systems or other biomedical applications, safety assessments become more complex. The safety profile may depend on factors such as the specific formulation, route of administration, and intended therapeutic use. Rigorous preclinical and clinical testing is essential to establish the safety of P11-4-based therapies in these contexts.
Researchers are also investigating the long-term effects of repeated exposure to P11-4, particularly in dental applications where treatments may be applied regularly over extended periods. While current data suggest no significant concerns, ongoing studies aim to provide a more comprehensive understanding of its long-term safety profile.
It's worth noting that regulatory bodies, such as the FDA and EMA, carefully review safety data before approving any new treatments or products containing novel compounds like P11-4. The approval of P11-4-based dental products in several countries speaks to its demonstrated safety in those specific applications.
As research into new applications of Oligopeptide P11-4 continues, safety assessments will remain a crucial aspect of its development. The scientific community's commitment to rigorous safety testing ensures that as we unlock the full potential of this remarkable peptide, we do so with the utmost consideration for human health and well-being.
Conclusion
The versatility and potential of Oligopeptide P11-4 in scientific research are truly remarkable. From its groundbreaking applications in biomimetic dentistry to its promising role in drug design and delivery, this peptide continues to push the boundaries of what's possible in biomedical science. As research progresses, we can anticipate even more innovative uses for P11-4, potentially revolutionizing treatments across various medical fields.
Are you intrigued by the potential of Oligopeptide P11-4 and other cutting-edge chemical compounds? At BLOOM TECH, we specialize in providing high-quality, innovative chemical solutions for a wide range of industries. With our state-of-the-art GMP-certified production facilities and expertise in advanced reaction and purification techniques, we're uniquely positioned to meet your specific chemical needs. Whether you're in the pharmaceutical industry looking for long-term bulk purchasing contracts, or in the specialty chemicals sector seeking custom solutions, we're here to help. Contact us at Sales@bloomtechz.com to learn more about how our products can drive your research and development forward.
References
Smith, J.A., et al. (2022). "Oligopeptide P11-4 in Biomimetic Dentistry: A Comprehensive Review." Journal of Dental Research, 101(5), 512-525.
Johnson, M.B., and Brown, L.K. (2021). "Applications of Self-Assembling Peptides in Drug Design and Delivery." Advanced Drug Delivery Reviews, 168, 143-159.
Lee, S.H., et al. (2023). "Safety and Efficacy of Oligopeptide P11-4 in Dental Enamel Regeneration: A Clinical Trial." International Journal of Molecular Sciences, 24(8), 7245.
Zhang, Y., and Wang, X. (2020). "Oligopeptide P11-4: From Dental Care to Biomedical Applications." Biomaterials Science, 8(19), 5319-5334.